1 Min Read
Feb 14 (Reuters) - Ligand Pharmaceuticals Inc :
* Dr. Christel Iffland joins Ligand as vice president, Antibody Technologies, expands team focused on OMNIAB drug discovery platform Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.